{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:45:03Z","timestamp":1790707503436,"version":"4.1.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVE:<\/jats:title>\n            <jats:p>To correlate neonatal and infant clinical outcome with parasite load in amniotic fluid (AF).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS:<\/jats:title>\n            <jats:p>We conducted a retrospective cohort study of 122 children whose mothers had toxoplasmosis during pregnancy. The children were monitored from birth to 12 months old. Stored AF samples were obtained at maternal diagnosis and tested by quantitative polymerase chain reaction. Gestational age at maternal infection, quantitative polymerase chain reaction results, neonatal anti\u2013<jats:italic toggle=\"yes\">Toxoplasma gondii<\/jats:italic> immunoglobulin (Ig) M, and clinical outcome at 12 months were correlated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>Maternal infection occurred in 18 of 122 (14.7%) and 104 of 122 (85.2%) women in the first and second trimesters, respectively. At birth, IgM was present in 107 of 122 (87.7%) neonates and 36 (29.5%) were symptomatic. Of these, half occurred in the first and the other half in the second trimester and 6 of 36 had severe infections (16.7% of symptomatic, 4.9% of total), all infected in the first trimester. Parasite load levels were highly variable (median 35 parasites\/mL, range 2\u201330,473). Logistic regression correlated symptomatic infection with gestational age (odds ratio [OR] 0.47, CI 0.31\u20130.73) and parasite load (OR 2.04, CI 1.23\u20133.37), but not with positive IgM (OR 6.81, CI 0.86\u201353.9). Negative correlations were found between gestational age and parasite load (rs \u20130.780, CI \u22120.843 to \u22120.696), gestational age and symptoms (rs \u20130.664, CI \u22120.755 to \u22120.547), but not gestational age and IgM (rs \u22120.136, CI \u22120.311 to 0.048). Parasite load levels distributed by percentile showed that all symptomatic patients appeared from the 75th percentile and all severe infections from the 95th percentile. Load rankings showed doubled the OR for each 20 parasite\/mL increment. Parasite load was associated with symptomatic infections (area under the curve 0.959, CI 0.908\u20130.987) as well as gestational age (area under the curve 0.918, CI 0.855\u20130.960) and both parameters combined (area under the curve 0.969, CI 0.920\u20130.992).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION:<\/jats:title>\n            <jats:p>Parasite load in AF is associated with the clinical outcome in congenital toxoplasmosis, irrespective of gestational age at maternal infection.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aog.0000000000002131","type":"journal-article","created":{"date-parts":[[2017,7,11]],"date-time":"2017-07-11T14:41:44Z","timestamp":1499784104000},"page":"335-345","source":"Crossref","is-referenced-by-count":22,"title":["Association of Parasite Load Levels in Amniotic Fluid With Clinical Outcome in Congenital Toxoplasmosis"],"prefix":"10.1097","volume":"130","author":[{"given":"Lidia","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00edlia S.","family":"Targa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"Sumita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo T.","family":"Shimokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonatas C.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly A.","family":"Kanunfre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thelma S.","family":"Okay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230711","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1017\/S0031182012000765","article-title":"Toxoplasmosis in humans and animals in Brazil: high prevalence, high burden of disease, and epidemiology","volume":"139","author":"Dubey","year":"2012","journal-title":"Parasitology"},{"issue":"suppl 1","key":"R2-20230711","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1016\/j.jinf.2013.09.023","article-title":"It is not only the cat that did it: how to prevent and treat congenital toxoplasmosis","volume":"68","author":"Robert-Gangneux","year":"2014","journal-title":"J Infect"},{"key":"R3-20230711","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/1097-0223(200102)21:2<85::AID-PD18>3.0.CO;2-1","article-title":"Prenatal diagnosis of congenital toxoplasmosis by duplex real-time PCR using fluorescence resonance energy transfer hybridization probes","volume":"21","author":"Costa","year":"2001","journal-title":"Prenat Diagn"},{"key":"R4-20230711","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.ajog.2003.09.039","article-title":"Usefulness of quantitative polymerase chain reaction in amniotic fluid as early prognostic marker of fetal infection with Toxoplasma gondii","volume":"190","author":"Romand","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"R5-20230711","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1016\/j.vaccine.2010.03.028","article-title":"Identification of T. gondii epitopes, adjuvants, and host genetic factors that influence protection of mice and humans","volume":"28","author":"Tan","year":"2010","journal-title":"Vaccine"},{"key":"R6-20230711","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/AOG.0b013e3181d57b09","article-title":"Accuracy of real-time polymerase chain reaction for Toxoplasma gondii in amniotic fluid","volume":"115","author":"Wallon","year":"2010","journal-title":"Obstet Gynecol"},{"key":"R7-20230711","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1080\/21505594.2016.1150401","article-title":"HLA-DQA1\/B1 alleles as putative susceptibility markers in congenital toxoplasmosis","volume":"7","author":"Shimokawa","year":"2016","journal-title":"Virulence"},{"key":"R8-20230711","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1590\/0037-8682-0095-2013","article-title":"The performance of four molecular methods for the laboratory diagnosis of congenital toxoplasmosis in amniotic fluid samples","volume":"46","author":"Teixeira","year":"2013","journal-title":"Rev Soc Bras Med Trop"},{"key":"R9-20230711","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1128\/JCM.00982-13","article-title":"Real-time PCR as a prognostic tool for human congenital toxoplasmosis","volume":"51","author":"Costa","year":"2013","journal-title":"J Clin Microbiol"},{"key":"R10-20230711","first-page":"117","article-title":"Improved technique of indirect immunofluorescence for serological diagnosis of toxoplasmosis","volume":"6","author":"Camargo","year":"1964","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"R11-20230711","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.3109\/14767058.2015.1074998","article-title":"Role of spiramycin in prevention of fetal toxoplasmosis","volume":"29","author":"Avci","year":"2016","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R13-20230711","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1128\/JCM.00487-16","article-title":"Laboratory diagnosis of congenital toxoplasmosis","volume":"54","author":"Pomares","year":"2016","journal-title":"J Clin Microbiol"},{"key":"R15-20230711","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/clinids\/18.1.38","article-title":"Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial","volume":"18","author":"McAuley","year":"1994","journal-title":"Clin Infect Dis"},{"key":"R16-20230711","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.siny.2007.01.011","article-title":"Toxoplasmosis","volume":"12","author":"Petersen","year":"2007","journal-title":"Semin Fetal Neonatal Med"},{"key":"R17-20230711","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1590\/S1807-59322009000300004","article-title":"Significant performance variation among PCR systems in diagnosing congenital toxoplasmosis in S\u00e3o Paulo, Brazil: analysis of 467 amniotic fluid samples","volume":"64","author":"Okay","year":"2009","journal-title":"Clinics (Sao Paulo)"},{"key":"R18-20230711","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1128\/jcm.27.8.1787-1792.1989","article-title":"Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction","volume":"27","author":"Burg","year":"1989","journal-title":"J Clin Microbiol"},{"key":"R19-20230711","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1756-0500-6-60","article-title":"Determining gestational age for public health care users in Brazil: comparison of methods and algorithm creation","volume":"6","author":"Pereira","year":"2013","journal-title":"BMC Res Notes"},{"key":"R20-20230711","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0029-7844(95)00386-X","article-title":"A United States national reference for fetal growth","volume":"87","author":"Alexander","year":"1996","journal-title":"Obstet Gynecol"},{"key":"R21-20230711","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.1941.02820090001001","article-title":"Toxoplasmic encephalitis in children","volume":"116","author":"Sabin","year":"1941","journal-title":"JAMA"},{"key":"R22-20230711","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1128\/JCM.02379-16","article-title":"Evaluation of the Toxoplasma ELITe MGB Real-Time PCR assay for the diagnosis of toxoplasmosis","volume":"55","author":"Robert-Gangneux","year":"2017","journal-title":"J Clin Microbiol"},{"key":"R23-20230711","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/cid\/cit032","article-title":"Congenital toxoplasma infection: monthly prenatal screening decreases transmission rate and improves clinical outcome at age 3 years","volume":"56","author":"Wallon","year":"2013","journal-title":"Clin Infect Dis"},{"key":"R24-20230711","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1056\/NEJM198802043180502","article-title":"Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis","volume":"318","author":"Daffos","year":"1988","journal-title":"N Engl J Med"},{"key":"R25-20230711","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1056\/NEJM197405162902003","article-title":"Congenital toxoplasmosis. A prospective study of 378 pregnancies","volume":"290","author":"Desmonts","year":"1974","journal-title":"N Engl J Med"},{"key":"R26-20230711","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(98)08220-8","article-title":"Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling","volume":"353","author":"Dunn","year":"1999","journal-title":"Lancet"},{"key":"R27-20230711","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0020-7519(99)00170-8","article-title":"Identification of a 200- to 300-fold repetitive 529 bp DNA fragment in Toxoplasma gondii, and its use for diagnostic and quantitative PCR","volume":"30","author":"Homan","year":"2000","journal-title":"Int J Parasitol"},{"key":"R28-20230711","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1590\/S0074-02762009000200028","article-title":"When are we going to celebrate the centenary of the discovery of efficient treatment for congenital toxoplasmosis?","volume":"104","author":"Peyron","year":"2009","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"R29-20230711","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1186\/1471-2334-14-349","article-title":"Assessment of laboratory methods used in the diagnosis of congenital toxoplasmosis after maternal treatment with spiramycin in pregnancy","volume":"14","author":"Rodrigues","year":"2014","journal-title":"BMC Infect Dis"},{"key":"R30-20230711","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1128\/AAC.38.9.1930","article-title":"Effectiveness of spiramycin for treatment of congenital Toxoplasma gondii infection in rhesus monkeys","volume":"38","author":"Schoondermark-Van de Ven","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"R31-20230711","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s10096-001-0644-6","article-title":"Treatment of toxoplasmosis in pregnancy: concentrations of spiramycin and neospiramycin in maternal serum and amniotic fluid","volume":"21","author":"Gratzl","year":"2002","journal-title":"Eur J Clin Microbiol Infect Dis"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006250-201708000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T19:40:26Z","timestamp":1689104426000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201708000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000002131","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]}}}